EIQ.AX is trading 24.2% up today at A$1.54 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus.

  • The deal includes an initial A$10 million investment by Pro Medicus to support the commercialisation of Echo IQ’s AI-powered cardiology products.
  • The partnership establishes a collaboration to sell Echo IQ’s technology in the U.S., which investors view as a major commercialisation and validation milestone for the company.